Cite
HARVARD Citation
Schofield, D. et al. (2021). Activity of murine surrogate antibodies for durvalumab and tremelimumab lacking effector function and the ability to deplete regulatory T cells in mouse models of cancer. MAbs. 13 (1), p. . [Online].